ArticleRare tumors2023

PARP inhibition utilized in combination therapy with Olaparib-Temozolomide to achieve disease stabilization in a rare case of BRCA1-mutant, metastatic myxopapillary ependymoma.

Preethika Mahalingam et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.